Insulet

Historical price data

Insulet Corporation is a mission-driven leader in tubeless insulin pump technology, dedicated to simplifying diabetes management and improving quality of life. Its core achievement is the Omnipod 5 Automated Insulin Delivery System, the #1 prescribed insulin pump, which has demonstrated significant clinical benefits in both type 1 and type 2 diabetes. The company's strategy leverages a disruptive pharmacy benefit distribution model to build direct patient relationships and drive adoption, supported by innovative marketing and a pipeline focused on expanding indications and platform integration.

The Omnipod platform is a tubeless, wearable insulin delivery system consisting of a disposable Pod (insulin reservoir, pump, cannula) and a smartphone-compatible Controller that runs a hybrid closed-loop algorithm, automating insulin adjustments based on continuous glucose monitor data.

Insulet's primary competitors are Medtronic and Tandem Diabetes Care, which offer tubed automated insulin delivery systems through the traditional durable medical equipment channel. Insulet's key advantages are its unique tubeless form factor, its disruptive pharmacy benefit distribution model, and its smartphone control option, which together create a differentiated user experience and lower access barriers.